Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heartcel in Patients Undergoing CABG Surgery
NCT03515291Phase 2Unknown
- Start
- Jan 2020
- Primary completion
- Jan 2021
- Modality
- Stem Cell Therapies
01
Overview
Phase 2, randomised, double-blind trial of Heartcel in myocardial fibrosis and ischemic heart disease (IHD) (2 arms). Primary endpoint: Late Gadolinium Enhanced Magnetic Resonance Imaging at 15 weeks. Status: unknown.
02
Drugs
Heartcel
03
Conditions
myocardial fibrosisischemic heart disease (IHD)
Beyond the preview
Go deeper on NCT03515291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03515291.